Dynamics of Tumor Stem Cells in Cancer Initiation, Therapy, and Resistance

Information

  • Research Project
  • 7623788
  • ApplicationId
    7623788
  • Core Project Number
    R01CA138234
  • Full Project Number
    1R01CA138234-01
  • Serial Number
    138234
  • FOA Number
    RFA-CA-08-19
  • Sub Project Id
  • Project Start Date
    9/24/2008 - 16 years ago
  • Project End Date
    7/31/2013 - 11 years ago
  • Program Officer Name
    ARYA, SURESH
  • Budget Start Date
    9/24/2008 - 16 years ago
  • Budget End Date
    7/31/2009 - 15 years ago
  • Fiscal Year
    2008
  • Support Year
    1
  • Suffix
  • Award Notice Date
    9/24/2008 - 16 years ago

Dynamics of Tumor Stem Cells in Cancer Initiation, Therapy, and Resistance

[unreadable] DESCRIPTION (provided by applicant): Human cancers are sustained in their growth by a pathological counterpart of normal adult stem cells, cancer stem cells. This concept was first described in human myeloid leukemias and has later been extended to solid tumors such as breast and brain cancer. A quantitative understanding of cancer stem cells requires a mathematical framework to describe the dynamics of cancer initiation and progression, the response to treatment, and the evolution of resistance. In this proposal, we suggest to use mathematical and experimental techniques to investigate the biology of cancer stem cells. We will derive mathematical models to investigate the cell of origin of human cancers, the behavior of cancer stem cells during therapy, and the evolution of resistance to anti-cancer drugs. We will use chronic myeloid leukemia (CML) treated with ABL tyrosine kinase inhibitors as a particular example and will validate the predictions of the mathematical models in a murine model of CML. Our approach will provide a validated quantitative understanding of cancer stem cells, and allow us to apply mathematical modeling of cancer stem cells to biologically and clinically important issues including response to targeted therapies and evolution of drug resistance. [unreadable] The Specific Aims are [unreadable] 1. To design a mathematical framework of CML stem cells. [unreadable] 2. To validate the predictions derived in Aim 1 in a murine model of CML. [unreadable] 3. To study the dynamics of resistance to anti-cancer therapy. [unreadable] 4. To investigate the cell of origin of CML. [unreadable] The research program outlined in this proposal will establish a quantitative understanding of tumor stem cells in cancer initiation, progression, treatment, and resistance and will provide theoretical frameworks indispensable for the understanding of cancer stem cell biology and the optimum administration of therapies. We will also test our mathematical models in an in vivo system, in order to demonstrate the relevance of our mathematical models to an experimental model. Although outside the scope of this proposal, the ultimate goal of this research program is to use mathematical models to develop a general framework for evaluating the role of cancer stem cells in oncogenesis, and to develop specific therapies which target cancer stem cells for human malignancies. [unreadable] [unreadable] [unreadable] [unreadable]

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R01
  • Administering IC
    CA
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    499289
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    395
  • Ed Inst. Type
  • Funding ICs
    NCI:499289\
  • Funding Mechanism
  • Study Section
    ZCA1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    SLOAN-KETTERING INSTITUTE FOR CANCER RES
  • Organization Department
  • Organization DUNS
    064931884
  • Organization City
    NEW YORK
  • Organization State
    NY
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    10065
  • Organization District
    UNITED STATES